|
 
 |
| COMMENTARY |
|
| Year : 2014 | Volume
: 6
| Issue : 5 | Page : 229-230 |
|
The journey toward quality and patient safety in laboratory medicine continues
Mario Plebani
Department of Laboratory Medicine, University-Hospital of Padova, Padova, Italy
| Date of Web Publication | 21-May-2014 |
Correspondence Address:
Mario Plebani
Department of Laboratory Medicine, University Hospital of Padova, Padova
Italy
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1947-2714.132942
How to cite this article:
Plebani M. The journey toward quality and patient safety in laboratory medicine continues. North Am J Med Sci 2014;6:229-30 |
Errors in laboratory medicine have a completely different meaning today than they had a century ago. At that time, the term referred to defects in the analytical performance of the test itself, the so-called analytical phase. [1] A dramatic change in addressing the issue of errors in laboratory medicine started at the end of the 1990s, when a body of evidence has been accumulated demonstrating vulnerability in the pre- and postanalytical phases. [2],[3]
The study by Abdollahi and co-workers confirms that more than 50% of errors are related to preanalytical steps, with 23.2% of errors in the intraanalytical and 11.7% in the postanalytical phase, respectively. [4] In addition, this study provides further evidence that the frequency of errors in inpatients is significantly higher than in outpatients due to several problems:
- Not always standard operating procedures (SOP) for test request, sample collection, handling, and transportation are followed by healthcare personnel who are not under the direct control of the laboratory;
- The complexity of some preanalytical steps (namely blood drawing) is higher for inpatients, due to age and disease issues;
- The trend toward consolidation and commoditization of laboratory services is decreasing the quality of communication between clinicians and laboratory professionals.
The "take-home" message is the need to consensually develop and adopt SOP for safely performing patient identification and preparation, test requesting, sample collection and handling and that harmonization initiatives should be performed to improve procedures and processes at the laboratory-clinical interface. It seems likely that only a small proportion of laboratory errors results in actual patient harm and adverse events thanks to the several barriers and defensive layers present between the release of laboratory information, the decision-making process and, ultimately, the action on the patient. However, from a risk management viewpoint, even the great majority of laboratory errors with little direct impact on patient care provide important learning opportunities. In fact, any error, regardless of its apparent triviality, might indicate weaknesses in policies and procedures that may not lead to adverse events in their particular context, but might cause the patient harm in slightly different circumstances. An important step in the journey toward the reduction of the error rates in laboratory medicine is the implementation of a valuable quality system according to the International Standard ISO 15189:2012 and of reliable quality indicators (QIs) covering all steps of the intra- and extra-analytical phases of the total testing process (TTP).[5]
It has been demonstrated that performance and outcome measures improve the quality of patient care and, in particular, QIs represent valuable tools for quantifying the quality of selected aspects of care by comparing it against a defined criterion. The measurement and monitoring of QIs in laboratory medicine serve many purposes as they make possible to:
- Document the quality of the service provided;
- Improve performance and patient safety;
- Make comparison (benchmarking) over time between laboratories;
- Make judgments and set priorities (corrective actions to be performed); and
- Support accountability, quality improvement and accreditation.
Recently a set of QIs has been consensually defined to allow clinical laboratories to measure and improve the quality of all steps of the TTP. The journey toward quality and patient safety continues.
| References | |  |
| 1. | Plebani M. The detection and prevention of errors in laboratory medicine. Ann Clin Biochem 2010;47:101-10. 
[PUBMED] |
| 2. | Plebani M, Carraro P. Mistakes in a stat laboratory: Types and frequency. Clin Chem 1997;43:1348-51.
|
| 3. | Carraro P, Plebani M. Errors in a stat laboratory: Types and frequencies 10 years later. Clin Chem 2007;53:1338-42.
|
| 4. | Abdollahi A, Saffar H. Types and frequency of errors during different phases of testing at a clinical medical laboratory of a teaching hospital in Teheran, Iran. N Am J Med Sci 2014; 224-228.
|
| 5. | Plebani M, Astion ML, Barth JH, Chen W, de Oliveira Galoro CA, Escuer MI, et al. Harmonization of quality indicators in laboratory medicine. A preliminary consensus. Clin Chem Lab Med 2014. [In Press].
|
| This article has been cited by | | 1 |
COVID-19-another influential event impacts on laboratory medicine management |
|
| YunTao Luo,JingHua Wang,MinMin Zhang,QingZhong Wang,Rong Chen,XueLiang Wang,HuaLiang Wang | | Journal of Clinical Laboratory Analysis. 2021; | | [Pubmed] | [DOI] | | | 2 |
Analytical performance assessment and improvement by means of the Failure mode and effect analysis (FMEA) |
|
| Leonor Guiñón,Anna Soler,Mónica Gisell Díaz,Rosa María Fernández,Nayra Rico,Josep Lluís Bedini,Aurea Mira,Luisa Alvarez | | Biochemia Medica. 2020; 30(2) | | [Pubmed] | [DOI] | | | 3 |
Analysis and evaluation of the external quality assessment results of quality indicators in laboratory medicine all over China from 2015 to 2018 |
|
| Min Duan,Fengfeng Kang,Haijian Zhao,Wei Wang,Yuxuan Du,Falin He,Kun Zhong,Shuai Yuan,Bingquan Chen,Zhiguo Wang | | Clinical Chemistry and Laboratory Medicine (CCLM). 2018; 0(0) | | [Pubmed] | [DOI] | | | 4 |
Identifying risk in the use of tumor markers to improve patient safety |
|
| Elvira Eva Moreno-Campoy,Francisco J. Mérida-De la Torre,Francisco Martos-Crespo,Mario Plebani | | Clinical Chemistry and Laboratory Medicine (CCLM). 2016; 0(0) | | [Pubmed] | [DOI] | | | 5 |
Building a bridge to safe diagnosis in health care. The role of the clinical laboratory |
|
| Giuseppe Lippi,Mario Plebani,Mark L. Graber | | Clinical Chemistry and Laboratory Medicine (CCLM). 2016; 54(1): 1 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
Search Pubmed for